Longeveron Inc. (LGVN)
NASDAQ: LGVN · Real-Time Price · USD
0.7501
-0.0878 (-10.48%)
At close: May 12, 2026, 4:00 PM EDT
0.7684
+0.0183 (2.44%)
After-hours: May 12, 2026, 7:53 PM EDT
Longeveron Market Cap
Longeveron has a market cap or net worth of $21.96 million as of May 12, 2026. Its market cap has decreased by -16.09% in one year.
Market Cap
21.96M
Enterprise Value
18.13M
1-Year Change
-16.09%
Ranking
Category
Stock Price
$0.75
Market Cap Chart
Since the IPO on February 12, 2021, Longeveron's market cap has decreased from $172.48M to $21.96M, a decrease of -87.27%. That is a compound annual growth rate of -32.50%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 11, 2026 | 24.53M | 127.29% |
| Dec 31, 2025 | 10.79M | -57.95% |
| Dec 31, 2024 | 25.67M | -24.83% |
| Dec 29, 2023 | 34.15M | -49.55% |
| Dec 30, 2022 | 67.68M | -72.36% |
| Dec 31, 2021 | 244.90M | 41.99% |
| Feb 12, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Barinthus Biotherapeutics | 27.98M |
| Vistagen Therapeutics | 26.47M |
| Allarity Therapeutics | 26.13M |
| Jasper Therapeutics | 25.87M |
| Dyadic International | 25.65M |
| Outlook Therapeutics | 25.40M |
| ABVC BioPharma | 25.08M |
| Serina Therapeutics | 24.58M |